Le père 48 ans, est chauffeur poids lourds, la mère 43 ans, 1991. ,
Le début des troubles semble remonter au week-end précédant son hospitalisation, marqué par des bizarreries (Guillaume voulait laisser ses baguettes de tambour chez le boulanger) Le médecin traitant a été appelé. Ce dernier prescrit des neuroleptiques mais Guillaume refuse. Le lendemain, devant l'importance des troubles, 1991. ,
Schizophrénie: diagnostic et prise en charge. Issy-les-Moulineaux, 2013. ,
??pid??miologie des troubles psychiatriques, Annales M??dico-psychologiques, revue psychiatrique, vol.166, issue.1, pp.63-70, 2008. ,
DOI : 10.1016/j.amp.2007.11.010
In: Manuel de psychiatrie clinique et psychopathologique de l'adulte. puf. Paris; 2012, pp.459-73 ,
Clozapine for Treatment-Resistant Schizophrenia: National Institute of Clinical Excellence (NICE) Guidance in the Real World, Clinical Schizophrenia & Related Psychoses, vol.4, issue.1, pp.49-55, 2010. ,
DOI : 10.3371/CSRP.4.1.4
Clozapine for the Treatment-Resistant Schizophrenic, Archives of General Psychiatry, vol.45, issue.9, pp.789-96, 1988. ,
DOI : 10.1001/archpsyc.1988.01800330013001
A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia, American Journal of Psychiatry, vol.168, issue.6, pp.603-612, 2011. ,
DOI : 10.1176/appi.ajp.2011.10081224
Evidencs-based guidelines for the pharmacological treatment of schizophrénia: recommandations from the British association for psychopharmacology, J Psychopharmacol, issue.25, pp.567-620, 2011. ,
Classification internationale des maladies, dixième révision, chapitre V (F): Troubles mentaux et troubles du comportement, Descriptions cliniques et directives pour le diagnostic, 1993. ,
Manuel de psychiatrie clinique et psychopathologique de l'adulte. Paris: Puf, 2012. ,
??valuation de la notion de ????schizophr??nie r??sistante????. Aspects pharmacologiques et incidences des nouveaux antipsychotiques, Annales M??dico-psychologiques, revue psychiatrique, vol.162, issue.6, pp.441-52, 2004. ,
DOI : 10.1016/j.amp.2003.10.020
Un cas de résistance à l'insuline dans le traitement de la schizophrénie. Congrès des aliénistes, pp.346-349, 1938. ,
The long-term course of the schizophrenic psychoses, Psychol Med, vol.4, pp.244-54, 1974. ,
L'évolution des schizophrénies, Evol Psy, vol.7, pp.1219-1262, 1977. ,
Therapeutic studies in ???therapy resistant??? schizophrenic patients, Comprehensive Psychiatry, vol.7, issue.6, pp.488-93, 1996. ,
DOI : 10.1016/S0010-440X(66)80028-7
Parental loxapine severely disturbed schizophrenic patients, J Clin Psychiatry, vol.41, issue.1, pp.23-29, 1980. ,
factor which can make patients difficult to treat, Schizophr Bull, vol.12, issue.31, pp.261-76, 1996. ,
Association de la clozapine à d'autres antipsychotiques atypiques dans le cadre de la prise en charge de la schizophrénie résistante [Thèse d'exercice], 2013. ,
Notion de schizophrénie résistante, pp.13-21, 1995. ,
Management of treatment resistance in schizophrenia, Biological Psychiatry, vol.50, issue.11, pp.898-911, 2001. ,
DOI : 10.1016/S0006-3223(01)01271-9
Treatment resistant schizophrenia and response to antipsychotics: A review, Schizophrenia Research, vol.133, issue.1-3, pp.54-62, 2011. ,
DOI : 10.1016/j.schres.2011.09.016
Practice guideline for the treatment of patients with schizophrenia, second edition, Am J Psychiatry, vol.161, issue.2, pp.1-56, 2004. ,
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia, The Journal of Clinical Psychiatry, vol.68, issue.11, pp.1751-62, 2007. ,
DOI : 10.4088/JCP.v68n1115
Commission de la transparence Avis du 30 novembre 2011. antipsychotiques de seconde génération, 2016. ,
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements, Schizophrenia Bulletin, vol.36, issue.1, pp.71-93, 2010. ,
DOI : 10.1093/schbul/sbp116
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance, The World Journal of Biological Psychiatry, vol.22, issue.1, pp.318-78, 2012. ,
DOI : 10.1016/j.schres.2007.02.009
Compliance, adherence and the therapeutic alliance: steps in the development of self-care, Soc Sci & Med, vol.12, pp.369-76, 1978. ,
??ducation th??rapeutique et schizophr??nie??: Quels buts???, Actualit??s Pharmaceutiques, vol.52, issue.524, pp.8-13, 2013. ,
DOI : 10.1016/j.actpha.2012.12.023
Observance du traitement en psychiatrie, EMC - Psychiatrie, vol.1, issue.1, 2003. ,
DOI : 10.1016/S0246-1072(03)00114-7
Schizophrénie résistante et ultra-résistante, Séminaire de Psychiatrie Biologique, vol.38, pp.161-81, 2008. ,
Insight et interventions psycho??ducationnelles dans la schizophr??nie, Annales M??dico-psychologiques, revue psychiatrique, vol.167, issue.10, pp.745-52, 2009. ,
DOI : 10.1016/j.amp.2008.04.007
Abstract, CNS Spectrums, vol.49, issue.S17, pp.21-27, 2007. ,
DOI : 10.4088/JCP.v66n0806
Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse, Schizophrenia Research, vol.54, issue.3, pp.253-64, 2002. ,
DOI : 10.1016/S0920-9964(01)00261-4
The Self-Medication Hypothesis of Addictive Disorders: Focus on Heroin and Cocaine Dependence, Am J Pscychiatry, vol.142, issue.11, pp.1259-64, 1985. ,
DOI : 10.1007/978-1-4613-1837-8_7
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications, Harvard Review of Psychiatry, vol.4, issue.5, pp.231-275, 1997. ,
DOI : 10.3109/10673229709030550
Schizophrenia and Cannabinoids, Drogues, sant?? et soci??t??, vol.2, issue.2, 2004. ,
DOI : 10.7202/008536ar
Evolution des psychoses: résultats d'une enquête clinique portant sur 383 cas suivi pendant dix ans (1975-1985), Ann Med Psychol, issue.1, pp.15-32, 1989. ,
Neuroleptic induced supersensitivity psychosis, Am J Psych, vol.135, pp.1409-1419, 1978. ,
A historical perspective of clozapine, pp.22-25, 1990. ,
In : médicaments antipsychotiques, évolution ou révolution ?, Olié J.P., Daléry J., Azorin J.M., Paris. Acanthe, pp.171-188, 2001. ,
Psychopharmacologie essentielle. 2002 e éd Paris: Flammarion, pp.431-433 ,
La clozapine: de la théorie à la pratique [Internet], Disponible sur, 1982. ,
Le monitorage thérapeutique de la clozapine : une nécessité clinique, Pharmactuel, vol.41, issue.2, pp.87-93, 2008. ,
Clozapine-induced bowel infarction: a case report, Psychiatry (Edgmont), vol.3, pp.30-35, 2009. ,
Clozapine-induced ischaemic colitis, Case Reports, vol.2013, issue.jan22 1, 2013. ,
DOI : 10.1136/bcr-2012-007933
Clozapine: fatal 'constipation' more common than fatal granulocytosis. New Zealand Medicines and Medical Devices Safety Authority, Prescriber Update, vol.28, 2007. ,
Clozapine-induced pericarditis: an overlooked adverse effect, Clin Schizophr Relat Psychoses. oct, vol.8, issue.3, pp.133-137, 2014. ,
Should obesity be a limiting factor for clozapine treatment? Rev Psiquiatr Salud Ment, juin, vol.6, issue.2, pp.75-84, 2013. ,
Clozapine induced tubulointerstitial nephritis in a patient with paranoid schizophrenia, Case Reports, vol.68, issue.may20 1, 2014. ,
DOI : 10.1136/bcr-2013-203502
Clozapine induced akathisia: A case report and review of the evidence, Indian Journal of Pharmacology, vol.47, issue.2, pp.234-239, 2015. ,
DOI : 10.4103/0253-7613.153441
Clozapine resistance: Augmentation strategies, European Neuropsychopharmacology, vol.22, issue.3, pp.165-82, 2012. ,
DOI : 10.1016/j.euroneuro.2011.08.005
Pharmacological Augmentation Strategies for Schizophrenia Patients With Insufficient Response to Clozapine: A Quantitative Literature Review, Schizophrenia Bulletin, vol.38, issue.5, 2011. ,
DOI : 10.1093/schbul/sbr004
Aripiprazole Augmentation in Clozapine-Treated Patients With Refractory Schizophrenia, The Journal of Clinical Psychiatry, vol.69, issue.5, pp.720-731, 2008. ,
DOI : 10.4088/JCP.v69n0505
Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial, The International Journal of Neuropsychopharmacology, vol.13, issue.08, pp.1115-1125, 2010. ,
DOI : 10.1017/S1461145710000490
Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study, Schizophrenia Research, vol.127, issue.1-3, pp.93-99, 2011. ,
DOI : 10.1016/j.schres.2010.12.011
Amisulpride augmentation of clozapine: an open non-randomized study in patients with schizophrenia partially responsive to clozapine, Acta Psychiatrica Scandinavica, vol.173, issue.44, pp.292-300, 2004. ,
DOI : 10.1001/archpsyc.60.6.553
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled study, The British Journal of Psychiatry, vol.171, issue.6 ,
DOI : 10.1192/bjp.171.6.569
Sulpiride Augmentation for Schizophrenia, Schizophrenia Bulletin, vol.36, issue.2, 2010. ,
DOI : 10.1093/schbul/sbp163
Augmentation of clozapine partial responders with conventional antipsychotics, Schizophrenia Research, vol.60, issue.1, pp.97-98, 2003. ,
DOI : 10.1016/S0920-9964(02)00293-1
P.3.c.037 Haloperidol in combination with clozapine in treatment-refractory patients with schizophrenia, European Neuropsychopharmacology, vol.16, p.416, 2006. ,
DOI : 10.1016/S0924-977X(06)70524-7
Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis, Schizophrenia Research, vol.123, issue.2-3, pp.225-233, 2010. ,
DOI : 10.1016/j.schres.2010.07.012
Topiramate Add-On in Treatment-Resistant Schizophrenia, The Journal of Clinical Psychiatry, vol.66, issue.08, pp.66-1012, 2005. ,
DOI : 10.4088/JCP.v66n0808
Adjunct Divalproex or Lithium to Clozapine in Treatment-Resistant Schizophrenia, Psychiatric Quarterly, vol.152, issue.2, pp.77-81, 2006. ,
DOI : 10.1007/s11126-006-7963-9
Fluvoxamine Reduces the Clozapine Dosage Needed in Refractory Schizophrenic Patients, The Journal of Clinical Psychiatry, vol.61, issue.8, pp.61-594, 2000. ,
DOI : 10.4088/JCP.v61n0809
Fluvoxamine augmentation in clozapine-resistant schizophrenia: an open pilot study, Biological Psychiatry, vol.40, issue.7, pp.671-674, 1996. ,
DOI : 10.1016/0006-3223(96)00170-9
Fluoxetine augmentation of clozapine treatment in patients with schizophrenia, Am. J. Psychiatry, vol.153, pp.1625-1627, 1996. ,
The history of clozapine and its emergence in the US market: a review and analysis, History of Psychiatry, vol.18, issue.1, pp.39-60, 2007. ,
DOI : 10.1177/0957154X07070335
Delay in starting clozapine and treatment guidelines, Br J Psychiatry J Ment Sci. févr, vol.202, pp.154-159, 2013. ,
Adherence to treatment guidelines in clinical practice: study of antipsychotic treatment prior to clozapine initiation, The British Journal of Psychiatry, vol.201, issue.6, pp.481-486, 2012. ,
DOI : 10.1192/bjp.bp.111.105833
Identifying treatment-resistant schizophrenia, The British Journal of Psychiatry, vol.202, issue.3, p.238, 2013. ,
DOI : 10.1192/bjp.202.3.238
Clinician hesitation prior to clozapine initiation: is it justifiable?, The British Journal of Psychiatry, vol.201, issue.6, pp.425-432, 2012. ,
DOI : 10.1192/bjp.bp.112.114777
Psychiatrists??? attitude towards and knowledge of clozapine treatment, Journal of Psychopharmacology, vol.93, issue.1, pp.965-71, 2010. ,
DOI : 10.1177/0269881108100320
Psychiatrists' perspectives regarding antipsychosis: Dose choice and plasma level drug monitoring, J Psychopharmacol, vol.26, issue.A39, 2012. ,
Clozapine???s Role in the Treatment of First-Episode Schizophrenia, American Journal of Psychiatry, vol.170, issue.2, pp.146-51, 2013. ,
DOI : 10.1176/appi.ajp.2012.12060778
Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial, The British Journal of Psychiatry, vol.199, issue.4, pp.281-288, 2011. ,
DOI : 10.1192/bjp.bp.110.081471
Historique de la sismothérapie, synapse, vol.137, pp.29-30, 1997. ,
The Practice of Electroconvulsive Therapy Recommandation for treatment, training and Privileging: A Task Force report of the AmericanPsychiatric Association, American Psychiatric Association, 2001. ,
Effectiveness and clinical predictors of response to combined ECT and antipsychotic therapy in patients with treatment-resistant schizophrenia and dominant negative symptoms, Psychiatry Research, vol.220, issue.1-2, pp.175-80, 2014. ,
DOI : 10.1016/j.psychres.2014.07.071
Efficacy of Different Antipsyhotics in Combination with ECT in Resistant Schizophrenia, European Psychiatry, vol.30, p.1622, 2015. ,
DOI : 10.1016/S0924-9338(15)31252-9
ECT rekindles pharmacological response in schizophrenia, European Psychiatry, vol.24, issue.8, pp.521-526, 2009. ,
DOI : 10.1016/j.eurpsy.2009.04.005
Consider ECT for Treatment-Resistant Childhood Schizophrenia, American Journal of Psychiatry, vol.171, issue.9, p.1000, 2014. ,
DOI : 10.1176/appi.ajp.2014.14050628
Management of Clozapine-Induced Fever in a Child, American Journal of Psychiatry, vol.171, issue.4, pp.398-402, 2014. ,
DOI : 10.1176/appi.ajp.2013.13070866
ECT for schizophrenia spectrum disorder, in Electroconvulsive Therapy in Children and Adolescents. 2013 e éd, pp.191-216 ,
La place de l?????lectroconvulsivoth??rapie dans le traitement des schizophr??nes, Annales M??dico-psychologiques, revue psychiatrique, vol.161, issue.8, pp.603-611, 2003. ,
DOI : 10.1016/j.amp.2003.08.003
Electroconvulsivothérapie, publié par le congrès de psychiatrie et de neurologie de Langue française, Masson, vol.192, 2001. ,
Maintenance electroconvulsive therapy (ECT) for treatment-resistant disorganized schizophrenia, Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol.31, issue.2, pp.571-574, 2007. ,
DOI : 10.1016/j.pnpbp.2006.11.014
Efficacity and Safety of electroconvulsive therapy in deprssive disorders: a systematic review and meta-analysis, Lancet, issue.361, pp.799-808, 2003. ,
Side effects of electroconvulsive therapy, Depression and Anxiety, vol.150, issue.3, pp.130-134, 2000. ,
DOI : 10.1002/1520-6394(2000)12:3<130::AID-DA4>3.0.CO;2-C
The Cognitive Side Effects of Modern ECT, The Journal of ECT, vol.24, issue.1, pp.18-24, 2008. ,
DOI : 10.1097/YCT.0b013e31815d9611
Toward a definition of pychoeducation, Hosp and Comm Psych, vol.39, pp.666-673, 1988. ,
Thérapie psychoéducative familiale et psychoses chroniques Charleroi: Socrate, 1999. ,
Les effets de la psycho??ducation, Annales M??dico-psychologiques, revue psychiatrique, vol.169, issue.3, pp.184-191, 2011. ,
DOI : 10.1016/j.amp.2011.02.011
Family Psychoeducation, Social Skills Training, and Maintenance Chemotherapy in the Aftercare Treatment of Schizophrenia, Archives of General Psychiatry, vol.48, issue.4, pp.340-347, 1991. ,
DOI : 10.1001/archpsyc.1991.01810280056008
L'information : entre dire pour se protéger et informer pour permettre, Encéphale, vol.27, issue.NS1, pp.26-39, 2001. ,
Un programme d???information sur la maladie et ses traitements destin?? aux patients atteints de schizophr??nie??: P.A.C.T.??, Annales M??dico-psychologiques, revue psychiatrique, vol.160, issue.5-6, pp.416-436, 2002. ,
DOI : 10.1016/S0003-4487(02)00189-0
L???annonce du diagnostic de schizophr??nie. Analyse textuelle d???entretiens cliniques, Annales M??dico-psychologiques, revue psychiatrique, vol.166, issue.8, pp.599-605, 2008. ,
DOI : 10.1016/j.amp.2006.04.011
Education th??rapeutique des patients psychotiques : impact sur la r??-hospitalisation, Education Th??rapeutique du Patient - Therapeutic Patient Education, vol.2, issue.2, pp.125-156, 2010. ,
DOI : 10.1051/tpe/2010014
Psychoéducation: définition, historique, intérêt et limites In: Annales Médico-psychologiques, revue psychiatrique ,
Psychoéducation et schizophrénie : aléas d'une propédeutique. L'Information Psychiatrique, pp.81-709, 2005. ,
Prise en charge des familles de patients schizophr??nes, Annales M??dico-psychologiques, revue psychiatrique, vol.169, issue.3, pp.196-205, 2011. ,
DOI : 10.1016/j.amp.2011.02.015